chr16-23624112-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_024675.4(PALB2):c.2749-18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000612 in 1,545,328 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024675.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000520 AC: 79AN: 151940Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000296 AC: 73AN: 246298Hom.: 0 AF XY: 0.000262 AC XY: 35AN XY: 133600
GnomAD4 exome AF: 0.000622 AC: 867AN: 1393270Hom.: 1 Cov.: 26 AF XY: 0.000564 AC XY: 393AN XY: 696660
GnomAD4 genome AF: 0.000520 AC: 79AN: 152058Hom.: 0 Cov.: 32 AF XY: 0.000431 AC XY: 32AN XY: 74320
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
- -
Curators: Marc Tischkowitz, Arleen D. Auerbach. Submitter to LOVD: Marc Tischkowitz. -
- -
Familial cancer of breast Benign:3
This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. -
- -
- -
Hereditary cancer-predisposing syndrome Benign:3
- -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
not specified Benign:2
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
Breast and/or ovarian cancer Benign:1
- -
Hereditary breast ovarian cancer syndrome Benign:1
According to the ClinGen ACMG PALB2 v1.1.0 criteria we chose these criteria: BP4 (supporting benign): SpliceAI < 0,1, BS1 (strong benign): MAF 0,02989% in gnomAD V2,0,05% in gnomAD V3 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at